RA (n = 75) | axSpA (n = 61) | |
---|---|---|
Age at conception, years (median) | 31 (21–40) | 31 (22–41) |
Age at diagnosis, years (median) | 27 (20–38) | 24 (17–33) |
Rheumatoid factor-positive | 50 (66) | – |
HLA-B27-positive | – | 43 (70.5) |
axSpA with peripheral arthritis | – | 27 (44.3) |
Medication within 3 months before conception | ||
Methotrexatea | 2 (2.7) | – |
NSAIDs | 8 (10.7) | 18 (29.5) |
TNFib | 15 (20.0) | 24 (39.3) |
Glucocorticosteroidsc | 25 (33.3) | 5 (8.2) |
DMARDs | 29 (38.7) | 5 (8.2) |
SSZ | 18 (24.0) | 5 (8.2) |
HCQ | 8 (10.7) | |
SSZ and HCQ | 3 (4.0) |